We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Statins May Slow the Effects of Alzheimer's Disease

News  
Published: November 21, 2005 
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

By submitting your email address, you agree to receive email communications related to Technology Networks content, products, or our partners. You may unsubscribe from these communications at any time as we respect your privacy. View our Privacy Policy for more information.
Read time: Less than a minute

Cholesterol-lowering drugs like statins were found to slow the progression of Alzheimer's disease (AD) in a three year study of 342 AD patients (J. Neurol. Neurosurg. Psychiatry December, 2005; 76:1624-1629).

Researchers at the University of Lille and the University Hospital, Lille, France compared AD patients taking cholesterol-lowering medication including statins to AD patients with unmedicated high cholesterol levels and to AD patients with normal cholesterol.

They found that the use of cholesterol-lowering medication slowed the cognitive decline that is the hallmark of AD as compared to both the unmedicated high cholesterol group and the normal cholesterol group.

Nymox Pharmaceutical Corporation holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of AD.

Related Topic Pages
Neurodegeneration
Behavioral Neuroscience
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter